• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Prostate radiotherapy for metastatic hormone sensitive prostate cancer-myth or reality?转移性激素敏感性前列腺癌的前列腺放疗——神话还是现实？
Transl Cancer Res. 2019 Nov;8(7):2508-2509. doi: 10.21037/tcr.2019.05.11.
2
WHO SHOULD RECEIVE RADIOTHERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER?转移性激素敏感性前列腺癌患者中哪些人应接受放疗？
Acta Clin Croat. 2019 Nov;58(Suppl 2):36-41. doi: 10.20471/acc.2019.58.s2.06.
3
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.转移性去势敏感性前列腺癌的前列腺放射治疗：STOPCAP 系统评价和荟萃分析。
Eur Urol. 2019 Jul;76(1):115-124. doi: 10.1016/j.eururo.2019.02.003. Epub 2019 Feb 28.
4
[Modern treatment of metastatic hormone-sensitive prostate cancer].[转移性激素敏感性前列腺癌的现代治疗]
Orv Hetil. 2018 Oct;159(41):1664-1671. doi: 10.1556/650.2018.31218.
5
Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer-a narrative review.新诊断的转移性激素敏感性前列腺癌的当前治疗选择——一篇叙述性综述
Transl Androl Urol. 2021 Oct;10(10):3918-3930. doi: 10.21037/tau-20-1118.
6
Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer.转移性激素敏感性前列腺癌一线药物治疗的现状及初始治疗的未来展望
Int J Urol. 2016 May;23(5):360-9. doi: 10.1111/iju.13091. Epub 2016 Apr 8.
7
Prostate radiotherapy in newly diagnosed metastatic prostate cancer.初诊转移性前列腺癌的前列腺放射治疗。
Curr Opin Urol. 2019 Nov;29(6):620-628. doi: 10.1097/MOU.0000000000000675.
8
Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches.靶向转移性激素敏感型前列腺癌：化疗联合激素治疗及新的联合治疗策略
J Urol. 2019 May;201(5):876-885. doi: 10.1097/JU.0000000000000117.
9
Hormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: a systematic review with meta-analyses.激素与放疗联合治疗与单纯激素或放疗治疗非转移性前列腺癌的比较：一项系统评价与荟萃分析
Clin Oncol (R Coll Radiol). 2014 Oct;26(10):e21-46. doi: 10.1016/j.clon.2014.06.016. Epub 2014 Jul 21.
10
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌诊治指南。第二部分-2020 年更新：复发性和转移性前列腺癌的治疗。
Eur Urol. 2021 Feb;79(2):263-282. doi: 10.1016/j.eururo.2020.09.046. Epub 2020 Oct 7.

本文引用的文献

1
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.转移性去势敏感性前列腺癌的前列腺放射治疗：STOPCAP 系统评价和荟萃分析。
Eur Urol. 2019 Jul;76(1):115-124. doi: 10.1016/j.eururo.2019.02.003. Epub 2019 Feb 28.
2
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.转移性去势抵抗性前列腺癌患者接受醋酸阿比特龙治疗后的局部区域放疗结果。
Strahlenther Onkol. 2019 Oct;195(10):872-881. doi: 10.1007/s00066-019-01429-6. Epub 2019 Jan 30.
3
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.新诊断转移性前列腺癌原发肿瘤放疗（STAMPEDE）：一项随机对照 3 期试验。
Lancet. 2018 Dec 1;392(10162):2353-2366. doi: 10.1016/S0140-6736(18)32486-3. Epub 2018 Oct 21.
4
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.在一项前瞻性随机临床试验中，比较单纯去势治疗与去势治疗联合前列腺同期放疗对原发性骨转移前列腺癌患者生存的影响：来自 HORRAD 试验的数据。
Eur Urol. 2019 Mar;75(3):410-418. doi: 10.1016/j.eururo.2018.09.008. Epub 2018 Sep 25.
5
NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.NCCN 指南更新：前列腺癌和前列腺癌早期检测。
J Natl Compr Canc Netw. 2018 May;16(5S):620-623. doi: 10.6004/jnccn.2018.0036.
6
Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.镓-PSMA-11 PET/CT在前列腺癌初始分期中的应用：前列腺特异抗原（PSA）和 Gleason评分可预测原发肿瘤中示踪剂摄取强度。
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949. doi: 10.1007/s00259-017-3631-6. Epub 2017 Jan 31.
7
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.转移性激素敏感性前列腺癌的化学激素疗法
N Engl J Med. 2015 Aug 20;373(8):737-46. doi: 10.1056/NEJMoa1503747. Epub 2015 Aug 5.
8
Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.根治性前列腺切除术或外照射放疗与不进行局部治疗对转移性前列腺癌生存获益的影响：一项监测、流行病学和最终结果（SEER）医保分析
J Urol. 2015 Aug;194(2):378-85. doi: 10.1016/j.juro.2015.02.084. Epub 2015 Feb 21.
9
Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study.基于 SEER 数据库的研究：在诊断为转移性前列腺癌的患者中，确定局部治疗原发肿瘤的最佳候选者。
Eur Urol. 2015 Jan;67(1):3-6. doi: 10.1016/j.eururo.2014.08.056. Epub 2014 Sep 10.
10
Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.高危前列腺癌患者轴向骨骼的磁共振成像用于检测骨转移：诊断及成本效益分析以及与当前检测策略的比较
J Clin Oncol. 2007 Aug 1;25(22):3281-7. doi: 10.1200/JCO.2006.09.2940.

Prostate radiotherapy for metastatic hormone sensitive prostate cancer-myth or reality?

作者信息

Onal Cem

机构信息

Department of Radiation Oncology, Baskent University Faculty of Medicine, Adana, Turkey.

出版信息

Transl Cancer Res. 2019 Nov;8(7):2508-2509. doi: 10.21037/tcr.2019.05.11.

DOI:10.21037/tcr.2019.05.11
PMID:35117005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8798566/
Abstract
摘要